Distribute healthcare to all: the lowest-cost path the country has not yet taken

International comparison cuts through the partisan fog. On a per-capita basis the United States spends nearly twice as much on healthcare as Germany and roughly four times as much as South Korea. The headline outcomes do not follow the spending. US life expectancy was 77.0 years in 2020 and 78.4 in 2023 — three to four years below the OECD average and the lowest among high-income countries. Maternal mortality is roughly 24 deaths per 100,000 live births, more than four times the peer-country rate of about 5. Infant mortality is 5.4 per 1,000 live births, against 1.6 in Norway and around 3 in the best-performing peer systems.

The pattern of excess is informative. Roughly 60% of US excess spending versus peer countries is driven by administrative overhead, inflated pharmaceutical prices, and elevated clinician wages — not by a greater volume of clinical care delivered. By volume the US has fewer physicians and beds per capita than its peers (2.8 beds per 1,000 against an OECD average of 4.3), but performs 44% more MRI scans and 62% more CT scans than the average. The system is optimized for high-intensity, high-cost imaging and specialty care rather than primary prevention. Hospitalizations for diabetes and hypertension — conditions highly preventable with timely primary care — are 50% higher than the OECD average. The US rate of hypertension hospitalizations is roughly eightfold higher than the Netherlands, the UK, and Canada. Sixteen percent of US adults use the emergency department for non-urgent care because primary-care access is blocked by financial barriers; the figure is 5% in the Netherlands and 7% in Germany.

Sources: OECD Health Statistics 2024; Commonwealth Fund US-vs-peer comparisons; CDC NCHS; Federal Reserve Financial Accounts.

Employer-sponsored health insurance is a historical accident — a workaround for World War II wage controls preserved in the tax code ever since. The structural consequences for the labor market are well documented and substantial. Job lock deters employees from changing jobs, starting businesses, or returning to school because doing so threatens coverage. Human capital mis-allocates; productivity is suppressed; entrepreneurship is taxed by a risk the rest of the OECD does not have.

When serious illness strikes, the same coupling creates a destructive feedback loop. Research shows illness leads to employment termination for about 38% of patient families.The patient loses income at the exact moment medical liabilities spike — and loses employer-sponsored coverage along with the job. COBRA is mathematically impossible for most displaced workers: the average family COBRA premium exceeds $1,000 per monthagainst an average unemployment benefit of $1,425 per month. The former math does not work even before rent, food, and the patient's own out-of-pocket medical bills.

The downstream effect is documented and large. A landmark Harvard study found that 62% of all US personal bankruptcies were attributable in part to medical expenses. The detail that usually surprises readers: 78% of those medically bankrupted had private health insurance at the onset of illness.Average out-of-pocket medical cost for the insured bankrupts was close to $18,000. Standard private coverage does not insure against financial collapse.

At population scale the lost productivity is measurable. Health-related work losses (absenteeism plus presenteeism) cost US employers more than $260 billion a year. Lost productivity from the uninsured population alone runs an estimated $124–248 billion a year in shortened lifespans and degraded labor-force participation. The uninsurance is structural: it does not exist in any other high-income country.

The single largest line item in US healthcare excess spending is not care. It is the cost of paying for care. Per OECD-comparison studies, about 60% of US excess spending versus peer nations is administrative overhead, drug-price inflation, and clinician-wage premium — not greater volume of clinical service. Single-payer systems operate with substantially lower administrative burden because providers bill one schedule rather than dozens.

The multi-payer structure also produces predictable risk-selection behavior. When different payers reimburse the same clinical service at vastly different rates, providers prioritize the highest-paying patients. Germany's two-tier insurance system is the canonical example: outpatient reimbursement rates for privately insured patients are two to three times those for publicly insured, and a randomized field experiment found publicly insured patients waited thirteen weekdays longer than privately insured patients for identical specialist appointments. The mechanism is not provider malice. It is the predictable response of any market to unequal prices for the same product.

The same dynamic plays out inside the US individual insurance market. Noncompliant plans (short-term, grandfathered) cream-skim healthy enrollees out of the ACA risk pool, leaving sicker, higher- cost lives behind in the compliant marketplaces, which pushes premiums up and accelerates the cycle. For-profit hospitals across the broader US market consistently report lower levels of uncompensated care as a share of net patient revenue than their non-profit counterparts — the shortfall absorbed by public hospitals and non-profit hospitals on uncompensated-care lines.

The waste compounds geographically. About 81% of US counties are healthcare deserts in at least one category — pharmacy, primary care, trauma, or hospital beds — and more than 120 million Americans live in one. The volume-based fee-for-service payment model is structurally hostile to low-density markets: rural hospitals cannot generate enough billable volume to cover fixed overhead, so they close. Between 2010 and 2022, 238 rural hospitals shut their obstetric units; only 41% of rural hospitals still have an active birthing service, and by 2024 roughly one-third of US counties had no obstetric provider or birthing facility at all.

The Accord's COMPASS shortage-indicator suite already names the mechanism: maternity-care deserts, trauma-access deserts, and primary- care HPSAs each trigger automatic Accord program activation when a tract crosses threshold. See /compass for the tract-level measurement and program-trigger architecture.

Defensive medicine — tests, procedures, or referrals ordered primarily to reduce malpractice exposure rather than to benefit the patient — is pervasive in US clinical practice. The Office of Technology Assessment's framing remains the standard: defensive medicine occurs “when doctors order tests, procedures, or visits, or avoid high-risk patients or procedures primarily (but not necessarily solely) to reduce their exposure to malpractice liability.”

Published estimates of the national cost vary too widely to publish a figure — the range across credible studies spans several multiples, and the Accord credits no dollar amount to it. What is measured is the behaviour. A hospitalist study found 28% of all medical orders were placed defensively, contributing to roughly 13% of total hospitalization costs. In Pennsylvania, 93% of surveyed physicians reported practicing defensively, with 43% naming advanced imaging as the most overused tool. In Massachusetts the figure was 83%, with 18–28% of all tests, procedures, and referrals ordered solely to manage liability.

The empirical irony is sharp. Higher-spending physicians face significantly fewer malpractice claims, which structurally rewards exhaustive over-testing regardless of clinical utility. High-risk specialties spend roughly 25% of a career defending claims even though about 80% of claims are ultimately resolved without finding of merit. The cost of the resulting clinical overutilization is paid by the patient: unnecessary CT radiation exposure, contrast-dye reactions, procedural complications, and antibiotic resistance from defensive broad-spectrum prescribing.

The Accord's Distributed Healthcare architecture is a payment-side consolidation that preserves clinical plurality on the delivery side. One federal payer buys the essential floor. Providers of every ownership form participate, and each service line enters whichever payment method matches its cost structure. Healthcare has four of them, and each one fails under the wrong method:

Delivery stays plural and regional. Private practices, nonprofit systems, public hospitals and tribal systems all participate, alongside a standing public arm of roughly 246 federally chartered Regional Health Authorities built on the community-governed health centre model. The VHA remains a veterans' system clinically, with its own governance and veteran priority — while supplying the institutional chassis the Authorities run on: Title 38 personnel authority and national credentialing, which took decades to build and cannot be procured.

The universal essential floor is comprehensive across categories: hospital, emergency, primary, specialty, and maternity care, mental health and substance-use treatment, prescriptions on the AHQB formulary, preventive care at $0 cost sharing, basic dental prevention, emergency vision exams, hearing screening, a fixed FedCard coupon for basic hearing aids and eyeglasses (about $500 per five years, approximate — never a reimbursement), and skilled post-acute care at Medicare-equivalent scope. A regulated supplemental (standardized tiers, guaranteed issue, community-rated, AHQB-supervised) sits on top as a financial and convenience layer on the same clinical floor — reduced cost sharing, comprehensive adult dental, premium vision and hearing devices above the coupon, private rooms — separately priced, with an AHQB one-way ratchet that migrates supplemental benefits into the floor as unit costs fall.

Inside the floor there is no prior authorization, no network denial and no balance billing. The American Healthcare Quality Board (AHQB) — a Senate-confirmed, methodology-audited expert panel — publishes national coverage indications, and a service furnished within an indication is paid on the clinician's attestation. Insurer discretion over the individual case is replaced by a published national rule that can be petitioned, appealed and taken to court.

Cost control is automatic rather than discretionary — the discipline the current system attempts and misses. Two tests govern: a warning that fires on sustained departure from the legislated spending path, and an outer backstop set beyond any modeled outcome. Both read access-adjusted spending — cash outlay plus the value of care demanded and not delivered — because spending that falls only because people could not obtain care is not a saving. Planning path, dated: about 19% of GDP at launch (2036), 15–16% by the 2050s, the 13.0% objective by the late 2070s, against 18.0% today and a projected 20.6% by 2034 under current law.

Two different things are often run together, and they should not be. The transition is binary and it is the ten-year plan: who is on the old plan and who is on the new one, who pays under which payment method, which institutions lose margin, which specialties take fee reductions, and which jobs end. Every one of those has a date. Enrollment completes at Year 7; the full phase-in is Year 10. Regional control is what makes that reachable — the Authorities convert existing facilities before building, so capital is $94B across the decade and construction binds nowhere.

Access is a trajectory, not a completion. Every American is covered for obstetric care on day one and at every point after; coverage is never partial. What varies is how far people travel — a distribution with a mean, a spread, and a tail — and the program's job is to move that distribution down through density and staffing. There is no percentage at which it is finished. The measure is the share of births more than 30 minutes from surgical delivery capability, and the honest milestone is the crossover: the year as many sites open as close. Rural obstetrics is net-closing today, and reaching that crossover plausibly takes twenty years. It does not belong on the transition clock. See /healthcare for the full mechanism, phase-by-phase, and /governance/debt-sunset for the macrogovernor that holds the system inside the corridor.

The architecture compounds: the move holds well over $1 trillion a year of directly comparable cost, and the bigger gains land downstream:

• Job lock dissolves. Coverage is no longer tied to a payroll job. Labor mobility recovers; entrepreneurship is no longer a tax on coverage. The $260 billion in annual employer work-loss cost shrinks; the $124–248 billion in uninsured-population productivity drag closes entirely.
• Medical bankruptcy as a category ends. The feedback loop that converts physical illness into financial ruin is severed at the structural step. The 62% bankruptcy share — and the 78% of medically bankrupted who already had insurance — both go to zero by mechanism, not by sympathy.
• The AHQB safe harbor removes one incentive for defensive medicine. When reimbursement rides on a Board-set schedule and the schedule itself defines the clinical standard of care, following the schedule carries statutory protection. Published estimates of the national cost vary across several multiples, so the Accord publishes none, and how much of it the safe harbor recovers is not established — the empirical literature on malpractice pressure and testing volume is inconclusive. Nothing from this mechanism is credited to the central score.
• Pharmacy benefit manager and interchange-style middleman extraction unwinds. One payer cannot be played against thirty. Drug-price inflation, the second- largest line in the 60% peer-comparison excess, comes down through reference pricing.
• The desert collapse is answered by capacity payment and a federally networked clinical workforce. Maternal mortality, rural obstetric closure and the one-third of counties without an obstetric provider are addressed by paying for standby capability that procedural volume cannot support, and by staffing it from a national pool rather than a local one. That mechanism already runs: VA Clinical Resource Hubs recorded over 1.2 million encounters in FY2024 and served 83% of VA medical centers, sharing clinicians across sites with local shortages.

Every component is already running somewhere at scale in the United States — Medicare's fee schedule, Maryland's hospital global budgets and the AHEAD model that succeeded them, the Rural Emergency Hospital and Pennsylvania Rural Health capacity designations, and the roughly 1,400 community-governed health centres serving more than 30 million people across some 15,000 sites. The country runs each piece. It has never matched them to cost structure under one payer.

• /healthcare — Engine 2 mechanism page. The full Distributed Healthcare architecture: the four payment methods, AHQB coverage determination, Regional Health Authorities and the standing public arm, and the build and workforce ramp.
• /governance/debt-sunset — the macrogovernor framework. Where the Healthcare Cost Brake sits among the Accord's five automatic stabilizers.
• /compass — the tract-level shortage-indicator suite. Maternity-care desert, primary-care HPSA, mental-health-provider shortage, and trauma-access desert all trigger Accord program activation when a tract crosses threshold.
• /calculator/family — household-level impact. Enter income, household size, and region; the calculator models the move from employer-tied premiums to the universal floor.